Table 5.
Country | Sex | Age (years) | Dose | Frequency/Days of Intervention | Sample Size | Design Study | Notes about Participants | Main Results | Ref. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
M | F | Exp. | CT | ||||||||
Infusion/Decoction/Tea | |||||||||||
Indonesia | NI | NI | 30–60 | 5 g | 14 days | 98 | 103 | Q | Pre-diabetic women | HS significantly decreased fasting blood glucose levels with no effect on postprandial glucose | [127] |
Indonesia | 0 | 18 | >60 | 2 g twice a day | 21 days | 9 | 9 | Q, CT | Subjects with metabolic syndrome | Postprandial glucose and cortisol levels were significantly reduced in subjects > 60 years of age | [112] |
USA | 4 | 4 | 18–43 | 10 g | 6 days | 6 | 6 | NI | One sample was collected per day for 6 days, 60 min after breakfast | HS together with a carbohydrate-rich breakfast appeared to slow the rate of increase in the glucose curve | [128] |
Capsule/Tablet | |||||||||||
Indonesia | NI | NI | 35–65 | 1 g | 8 weeks | 30 | 30 | Exp, DBT | The control group and the HS group presented homogeneous conditions | HS 500 mg 2 times a day can significantly reduce fasting blood glucose and insulin levels | [11] |
Beverage | |||||||||||
UK | NI | NI | 49 ± 2 | 7.5 g | 4 h | 22 | 22 | R, C, SB, CO | After 120 min of HS consumption, there was a tendency to a lower postprandial insulin response than the control group | [12] | |
Iran | 22 | 38 | 52 (mean) | 425 mg | 8 weeks | 30 | 30 | R, DBT, PC | Of the participants in the study, 80% used insulin, and 20% used glucose-lowering drugs | HS did not promote changes in fasting blood glucose levels in patients with diabetic nephropathy | [13] |
Cameroon | 32 | 0 | 25.38 ± 3.35 | 35 g | 2 weeks | 32 | 0 | NI | The preparation of the beverage granted contained sugar (180 g/L) | HS did not promote changes in blood glucose in healthy subjects aged 21 to 32 years | [121] |
NI: no information; HS: Hibiscus sabdariffa; M: male; F: female; Exp: experimental group; CT: control group; Q: quasi-experimental; DBT: double-blind trial; C: controlled trial; SB: single-blind trial; CO: cross-over trial; R: randomized trial; PC: placebo control.